Research

Ticker Move of the Day: MRVL -11.88% after announcing $115B all-stock Lumentum deal

Support · 1 min read · Nov 05, 2026, 6:30 AM PT

Marvell Technology shares tumbled 11.88% in regular trading on November 5, 2026, to $151.47, following the company's announcement on November 2 of a definitive merger agreement to acquire optical-chip maker Lumentum in an all-stock transaction valued at $115 billion in implied enterprise value. Under the fixed 4.5-share exchange ratio with no collar, Lumentum shareholders receive 4.5 Marvell shares per Lumentum share, but the deal's market value has already collapsed by more than a third as Marvell stock has declined sharply. Bank of America and TD Cowen both downgraded Marvell, citing concerns over equity dilution, the all-stock structure, regulatory risk, potential customer conflicts, and the challenge of integrating optical and silicon portfolios in a volatile AI infrastructure market. The fixed ratio means Lumentum's 24% acquisition premium has flipped to a 21% discount to its pre-deal price, signaling deep market doubt about deal completion or synergy realization. Investors face an uncertain 2028 closing timeline, merger execution risk, and the question of whether Marvell can effectively blend its high-speed electrical connectivity business with Lumentum's optical light sources to compete in AI data-center connectivity.

Research

Ticker Move of the Day: INTC -29% after weak Q4 forecast sparks chip sell-off

Support · 1 min read · Nov 02, 2026, 6:30 AM PT

Intel shares plummeted 29.04% in regular trading on November 2, 2026, to $65.34, marking a continuation of the 28.58% crash that began on October 30 when the company guided Q4 revenue to $15–$16 billion versus Wall Street's $17 billion consensus and warned of prolonged personal-computer weakness lasting into 2027. The chipmaker reported a strong Q3 beat with 20.9% year-over-year revenue growth to $16.5 billion and adjusted EPS of $0.52 versus $0.39 expected, but the forward guidance collapse overshadowed earnings results and an impressive 78% jump in data-center revenue. A $300 million revenue hit from an explosion at Intel's Israel manufacturing facility adds to near-term headwinds. The selling pressure extends across the semiconductor sector, with AMD and Marvell also down sharply today, as investors reassess chip demand amid data-center spending questions and Intel's admission that the PC market slowdown will persist. Traders are watching whether AMD's earnings on November 3 provide any clarity on the health of demand or whether the sector faces a broader reset.

Research

Ticker Move of the Day: INTC -28.39% after weak Q4 guidance overshadows earnings beat

Support · 1 min read · Oct 30, 2026, 7:30 AM PT

Intel shares plunged 28.39% in regular trading on October 30, 2026, after the company reported third-quarter earnings that beat expectations but issued a significantly weaker fourth-quarter revenue outlook. The chipmaker forecast Q4 adjusted earnings of $0.25 per share versus consensus of $0.43, and revenues of $15–$16 billion against Wall Street expectations near $17 billion. Weak personal computer demand and a manufacturing disruption in Israel citing a facility explosion contributed to the cautious guidance, despite Intel's data center and AI segment revenue surging nearly 80% annually to $7.3 billion, its strongest growth in 15 years. Management also confirmed that capital expenditures would rise sharply in 2027, with no positive free cash flow expected next year, heightening investor concern about near-term profitability and cash burn. Analysts noted the selloff marks one of Intel's worst single-session declines on record, erasing approximately $400 billion in market capitalization as investors shifted focus from AI tailwinds to execution risks and the PC market collapse.

Research

Ticker Move of the Day: ADT +34.08% after Thrive Holdings acquisition deal announced

Support · 1 min read · Oct 29, 2026, 7:30 AM PT

ADT Inc. surged 34.08% in regular trading on October 29, 2026, following the announcement of a definitive agreement for Thrive Holdings to acquire the company in an all-cash transaction valued at approximately $7.6 billion in equity. Shareholders will receive $10.00 per share, representing a 45.6% premium over ADT's unaffected closing price of $6.87 on October 27. The transaction, backed by Apollo-managed funds and unanimously approved by ADT's board, is expected to close in early 2027, subject to a go-shop period through November 28, 2026. Thrive's permanent capital structure will provide ADT with long-term financial flexibility to invest in technology, products, and talent while maintaining existing data privacy policies. The stock showed exceptional volume with 39.2 million shares traded, well above the average daily volume of approximately 9.5 million.

Research

Ticker Move of the Day: GMAB +21% on game-changing cancer trial Phase 3 win

Support · 1 min read · Oct 28, 2026, 7:30 AM PT

Genmab (NASDAQ:GMAB) surged 21% in regular trading on October 28 after announcing positive Phase 3 results for petosemtamab combined with Merck's Keytruda (pembrolizumab) in head and neck cancer. The LiGeR-HN1 trial met both primary endpoints at its first interim analysis, cutting the risk of death by 50% compared to pembrolizumab alone, with an overall survival hazard ratio of 0.50. The combination also showed a statistically significant improvement in objective response rate. JPMorgan upgraded Genmab to Overweight just yesterday, and TD Cowen raised its price target to $52, providing tailwind heading into today's announcement. The safety profile was reported as clean with no new safety signals identified, removing a key risk to investor enthusiasm. Genmab now looks to engage with regulatory authorities globally, and the strong data positions petosemtamab for potential near-term regulatory submissions in multiple oncology settings.

Research

Ticker Move of the Day: T -5.27% as SpaceX pushes to launch 4th wireless carrier

Support · 1 min read · Oct 23, 2026, 7:30 AM PT

AT&T shares slid 5.27% in regular trading on October 23 as Bloomberg reported that SpaceX is in talks for access to approximately 80,000 U.S. cell tower sites to build a fourth nationwide wireless carrier. The talks with major tower companies including Crown Castle represent SpaceX's latest move to complement its earlier October acquisition of 800 MHz spectrum from Grain Management. This fresh competitive threat compounds pressure on AT&T and peers T-Mobile and Verizon, all down sharply in both early and regular trading. While no tower leases are yet signed and the spectrum deal closes only in the first half of 2027, the convergence of SpaceX's satellite infrastructure, spectral assets, and tower access negotiations suggests a material competitive test ahead for legacy carriers. Investors are now focused on whether SpaceX can convert tower discussions into binding contracts and how quickly Starlink Mobile can operationalize as a terrestrial competitor.

Research

Ticker Move of the Day: BHVN +30% after FDA accepts Vyglxia NDA resubmission

Support · 1 min read · Oct 22, 2026, 7:30 AM PT

Biohaven Pharmaceuticals (BHVN) surged 30.3% in regular trading on October 22 after the FDA accepted its resubmission of the new drug application for Vyglxia (troriluzole), a treatment for spinocerebellar ataxia. The regulatory milestone signals the agency will complete its review under a standard timeline, potentially moving Vyglxia closer to commercial availability. Separately, Biohaven announced a $100 million non-dilutive licensing deal with Ono Pharmaceutical for its MoDE IgG degrader portfolio in Asian territories, retaining US and European rights for future monetization. The dual catalysts—regulatory progress on a mid-stage asset plus significant cash partnering revenue—address two key concerns for a clinical-stage biotech: development velocity and cash runway. Traders are now watching for the FDA's target action date and Phase 3 progress on BHV-1300 for Graves' disease.

Research

Ticker Move of the Day: SMCI +11.52% on blowout Q1 revenue guidance beat

Support · 1 min read · Oct 21, 2026, 7:31 AM PT

Super Micro Computer (SMCI) surged 11.52% in regular trading on October 21 following the company's late Tuesday announcement of preliminary first-quarter fiscal 2027 revenue of $18.5–$19.5 billion, crushing both prior guidance of $14.5–$15.5 billion and analyst consensus near $15 billion. The server maker also raised gross margin guidance to 12.0–12.5% from 10.4–10.8%, signaling improved profitability. The upside revision was driven by explosive demand for artificial intelligence server platforms, with implied year-over-year revenue growth of approximately 280%. Supermicro's guidance lift is expected to boost the entire AI infrastructure sector, including peers like Dell and HPE, and eases investor concerns about AI spending sustainability. The company will report official earnings on November 3, 2026 at 5 p.m. EST.

Research

Ticker Move of the Day: BRZE +51% after Salesforce agrees to acquire for $5.66B

Support · 1 min read · Oct 20, 2026, 7:30 AM PT

Braze (BRZE) surged 51% in regular trading on October 20 following Salesforce's announcement of a definitive agreement to acquire the customer engagement platform for approximately $5.66 billion in enterprise value. Salesforce will pay $47.50 per share in cash, representing a 58% premium to Braze's prior close of $30.04 on October 18. The acquisition strengthens Salesforce's Marketing Cloud and AI-powered customer engagement capabilities by integrating Braze's real-time messaging and personalization technology across mobile apps, web, email, SMS, and other channels. The transaction is expected to close in Salesforce's fiscal year 2028, subject to regulatory and shareholder approval, with Salesforce maintaining its fiscal 2027 guidance and funding the deal entirely from cash. Braze is now backed by customer giants including Canva, Instacart, Urban Outfitters, and Venmo, with recent reported revenue growth of 26.2% year-over-year to $227.2 million in the latest quarter.

Research

Ticker Move of the Day: FMC -34% after catastrophic Q3 guidance cut

Support · 1 min read · Oct 15, 2026, 7:30 AM PT

FMC Corporation stock plummeted 34% in regular trading on October 15 following a devastating pre-market guidance revision that shocked the market. The agricultural sciences company slashed its third-quarter revenue guidance to $65–$125 million from a prior $840–$900 million, and swung EBITDA guidance to a loss of $510–$565 million from a $120–$140 million profit. Management attributed the collapse to weaker-than-expected demand and bloated channel inventory, forcing aggressive commercial actions including targeted price cuts and a restructuring of U.S. pricing and sales operations. The combination of a 52-week low stock price, $625–$675 million in one-time impacts, and years of crop-protection pricing headwinds has triggered rapid analyst target cuts from major banks. Full third-quarter results and 2027 guidance will follow on October 29, leaving investors to assess whether management's structural turnaround can stabilize the deeply distressed balance sheet.

Research

Ticker Move of the Day: BSP +33% after Berkshire Hathaway $330M private placement

Support · 1 min read · Oct 14, 2026, 7:30 AM PT

Bending Spoons (BSP) surged 33% in regular trading on October 14 following Berkshire Hathaway's announcement of a $330 million private placement, increasing the investment giant's stake to 4%. The Italian software conglomerate is now backed by $930 million of Berkshire capital since its July 2026 IPO. Berkshire purchased 10 million shares at $33 per share, signaling continued confidence in BSP's AI-driven acquisition and operational-improvement strategy. The company has rapidly grown revenue through strategic acquisitions including Miro, Airtable, and others, posting 126% revenue growth in Q2 2026. Traders should monitor BSP's ability to sustain valuation multiples—currently trading at a trailing P/E of 180—as integration execution and organic growth metrics will determine whether Berkshire's large bet justifies its premium pricing.